This is the first in vivo biochemical study in humans to provide evidence that the vasodilatory effects of insulin are associated with activation of the L-arginine-NO pathway and this appears to be impaired in type 2 diabetes. The gene discussed is INS; the disease is type 2 diabetes mellitus.